Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial

Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial

The impact of chemotherapy resistant B cells in multiple myeloma (MM) needs to be evaluated by in vivo targeted therapy. Here we report the conclusions from a phase II randomized, placebo controlled trial adding fludarabine to the induction with cyclophosphamide-dexamethasone. Based on an interim t...

Full description

Bibliographic Details
Main Authors: Hans E. Johnsen, Lene M. Knudsen, Anne K. Mylin, Peter Gimsing, Henrik Gregersen, Niels Abildgaard, Niels Frost Andersen, Torben Plesner, Annette Vangsted, Torben Mourits-Andersen
Format: Article
Language:English
Published: MDPI AG 2009-08-01
Series:Hematology Reports
Subjects:
Multiple Myeloma
Clinical trial
Fludarabine
Online Access:http://www.pagepress.org/journals/index.php/hr/article/view/83

Internet

http://www.pagepress.org/journals/index.php/hr/article/view/83

Similar Items